Friday, July 30, 2010
Intercytex: Clarification regarding Strategic Review
Following the announcement of the negative trial results and initiation of a strategic review on 20 February 2009, Intercytex Group plc (LSE: ICX) (“Intercytex” or “the Company”) would like to clarify that the options under review include a possible merger or sale of the business.
Intercytex is therefore deemed to be in an Offer Period for the purposes of The Takeover Code.
Enquiries
For more information, contact:
|
Intercytex Group plc |
|
|
Nick Higgins, Chief Executive Officer |
Tel: 0161 904 4500 |
|
Max Herrmann, Chief Financial Officer |
|
|
|
|
|
Financial Dynamics |
|
|
Jonathan Birt |
Tel: 0207 269 7205 |
|
Emma Thompson |
Tel: 0207 269 7182 |
|
|
|
|
Piper Jaffray Ltd |
|
|
Will Carnwath |
Tel: 0203 142 8700 |
Published: 23rd Feb 2009 - 12:44:36
Modified: 23rd Feb 2009 - 12:44:57
